Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: codeine / sulfa (sulfonamides) attending: chief complaint: scheduled admission for ablative chemotherapy with tbi/cytoxan/fludarabine followed by cord blood transplantation of a double cord major surgical or invasive procedure: placement of r chest port-a-cath history of present illness: mrs. is a 35 y o f with a history of t-cell lymphoma with evidence of recurrent and refractory disease. she has undergone numerous rounds of chemotherapy. last chemotherapy was ontak chop on started on which was well tolerated. patient has known cns involvement and has undergone intrathecal depocyte treatment as recently as . she is currently on decadron. cord blood donors have been identified. her admission today is scheduled to begin her allogeneic cord blood transplantation. day 0 scheduled for . . on presentation to the floor patient denies recent fever, chills, nausea, diarrhea, rash, shortness of breath, or any upper respiratory tract symptoms. she admits to chronic peripheral neuropathy in feet which remains unchanged and r radial nerve palsy requiring a brace. she recently fractured her r humerus which she states is healing well and pain is well controlled. past medical history: past oncology history: peripheral t cell lymphoma (alk-1 negative) with cns involvement . the patient presented with fevers and elevated lft's in the spring of , at which time a bone marrow biopsy from an outside hospital demonstrated large lymphoid cells which were positive for cd30, along with cd56, cd2 (subset), and rare cd8 positive cells. the large cells were negative for pax-5, cd45, c15 and alk-1; cd20 and cd79a highlighted b cells; while cd3 stained t lymphocytes (subset). cd4, 5 and 7 highlighted most of the t cells. results of a repeat biopsy performed at were felt to be most consistent with peripheral t-cell lymphoma. . therapy has included high-dose steroids ; nitrogen mustard ; two cycles of chop ( and ); and three cycles of eshap (, , and ). in addition, she was given it mtx and it liposomal arac, most recently , for cns involvement. she has repeatedly experienced transient responses to chemotherapy with fevers and a rising ldh at the end of each chemotherapy cycle felt to be due to refractory disease. following her most recent treatment with eshap, she had temperatures of up to 105 without evidence of a source of infection. a repeat staging evaluation included a pet scan on , which demonstrated patchy marrow uptake in the vertebral bodies consistent with persistent disease. bone marrow biopsy showed large, atypical lymphoid cells which were cd30 negative but morphologically similar to her prior disease. workup has revealed no ongoing abnormalities in the liver, which was the site of her initial presentation. she was started on gemcitabine, vinorelbine, and dexamethasone on , with her day 8 dose of chemotherapy given on and intrathecal liposomal cytarabine on by dr. . in the meantime, a cord blood donor has been identified for possible allogeneic stem cell transplant. . . past medical history: 1. history of c. diff colitis 2. history of dvt 3. right radial nerve palsy 4. peripheral neuropathy of the lower extremities 5. g1p1 s/p c-section 2 years ago social history: the patient lives with her husband (her power of attorney) and their two and a half year old son. she denies using tobacco or alcohol. she rents space in a salon where she does manicures. family history: father has a history of a benign adrenal mass and has had skin cancers removed. her mother has hyperparathyroidism and hypertension. physical exam: vitals: t 99.2 bp 102/70 rr 20 hr 106 spo2 100% ra wt 149.3 lbs gen: nad, tearful skin: warm, dry, no rashes or lesions heent: eomi, mmm, no conjunctival pallor, anicteric, no oral lesions or erythema neck: supple, no lad, no jvd cv: rrr, no m/r/g resp: cta b, nonlabored breathing abd: +bs, soft, ntnd ext: r wrist in brace, no c/c/e neuro: r radial nerve palsy; bilateral peripheral neuropathy of feet pertinent results: admission labs: . 10:00am pt-11.7 ptt-21.1* inr(pt)-1.0 10:00am plt count-81* 10:00am hypochrom-normal anisocyt-2+ poikilocy-1+ macrocyt-2+ microcyt-normal polychrom-normal spherocyt-2+ ovalocyt-1+ teardrop-2+ 10:00am neuts-51 bands-23* lymphs-7* monos-8 eos-0 basos-1 atyps-0 metas-5* myelos-3* promyelo-2* 10:00am wbc-6.2 rbc-3.13* hgb-10.5* hct-29.5* mcv-94 mch-33.5* mchc-35.6* rdw-21.6* 10:00am tot prot-6.5 albumin-4.3 globulin-2.2 calcium-9.4 phosphate-3.7 magnesium-2.2 uric acid-3.0 10:00am alt(sgpt)-83* ast(sgot)-33 ld(ldh)-302* alk phos-173* tot bili-0.4 dir bili-0.1 indir bil-0.3 10:00am urea n-18 creat-0.4 sodium-138 potassium-4.4 chloride-101 total co2-30 anion gap-11 10:00am glucose-109* 04:41pm urine rbc-4* wbc-20* bacteria-few yeast-none epi-1 04:41pm urine blood-neg nitrite-neg protein-tr glucose-neg ketone-neg bilirubin-neg urobilngn-neg ph-5.5 leuk-neg 04:41pm urine color-yellow appear-hazy sp -1.026 . cxr: no acute cardiopulmonary abnormality identified . . specimen submitted: immunophenotyping, peripheral blood procedure date tissue received report date diagnosed by dr. /vf flow cytometry report flow cytometry immunophenotyping the following tests (antibodies) were performed: cd antigens 2, 3, 4 ,5, 7, 8, 16, 19, 56, 57. results: three color gating is performed (light scatter vs. cd45) to optimize lymphocyte yield. abnormal/lymphoma cells comprise 15% of total events. t cells comprise 92% of lymphoid gated events. interpretation immunophenotypic findings consistent with involvement by a t cell lymphoma with aberrant phenotype. lymphoma cells express cd2 and cd7 (only small subset, most cells being cd7 negative), but not cd3, cd4, cd8 or cd5. brief hospital course: ms. is a 35 year old woman with a history of t-cell lymphoma who was admitted for scheduled ablative chemotherapy with tbi and cytoxan followed by allogeneic cord stem cell transplant. . #) t cell lymphoma: the pt presented for scheduled allogeneic cord stem cell transplant (day 0 ). her conditioning regimen included: tbi, cytoxan, fludarabine as well as cellcept and tacrolimus. while receiving her stem cells mrs experienced rigors without fever. she was briefly covered with cefepime but the episode quickly passed and cefepime was stopped. the pt tolerated the transplant well and was weaned off of steroids per the transplant protocol. on the pt began to spike fevers and had blood cultures that grew vancomycin-resistant enterococcus. at that time the pt was started on daptomycin, and zosyn and casponfungin were added later as she continued to have fevers. on day 16 post transplant the pt was still awaiting recovery of her cell counts but had developed renal failure in the setting of likely tacrolimus toxicity and she was transfered to the icu for initiation of hemodialysis. at this time there was also mounting evidence (right upper quadrant, ascites) that the patient was developing -occlusive disease of the liver, and the pt was started on a protocol for treatment with defibrotide. on the pt's labs began to show evidence of engraftment, but soon after this the patient's fever curve began to increase as steroids were tapered. an extensive infectious work-up was pursued, but the pt was noted to have increasing numbers of atypical cells on her daily white blood cell differential which was concerning for a recurrence of the pt's hematologic malignancy. on the pt's peripheral smear showed evidence of lymphoma with leukemic transformation on peripheral blood. immunophenotyping of peripheral blood confirmed the presence of t cell lymphoma cell markers. on the care team met with the patient's family to discuss the patient's grave condition and the decision was made to change the pt's code status to dnr/dni and to continue to provide antibiotics and pain medication for comfort as the goal of care. on the pt expired. medications on admission: 1. acyclovir 200 mg capsule sig: two (2) capsule po q8h (every 8 hours). 2. amitriptyline 10 mg tablet sig: one (1) tablet po hs (at bedtime). 3. gabapentin 300 mg capsule sig: two (2) capsule po bid (2 times a day). 4. gabapentin 300 mg capsule sig: three (3) capsule po hs (at bedtime). 5. vancomycin 250 mg capsule sig: one (1) capsule po bid (2 times a day). 6. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 7. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day). 8. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 9. ondansetron 4 mg tablet, rapid dissolve sig: one (1) tablet, rapid dissolve po q8h (every 8 hours) as needed for nausea. 10. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours) as needed for fever. 11. dexamethasone 4 mg tablet sig: one (1) tablet po every twelve (12) hours for 4 days. disp:*8 tablet(s)* refills:*0* 12. magnesium oxide 400 mg tablet sig: one (1) tablet po once a day. 13. ativan 0.5 mg tablet sig: one (1) tablet po every 4-6 hours as needed. 14. pentamidine 300 mg recon soln sig: one (1) dose inhalation once a month. 15. fluconazole 200 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 16. lantus 100 unit/ml solution sig: eighteen (18) units subcutaneous at bedtime for 3 days. disp:*3 18 unit syringes* refills:*0* 17. insulin needles (disposable) 29 x needle sig: one (1) needle miscellaneous at bedtime. disp:*5 needles* refills:*0* discharge medications: none discharge disposition: expired discharge diagnosis: t cell lymphoma discharge condition: expired discharge instructions: n/a--pt expired followup instructions: n/a--pt expired md, procedure: venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances hemodialysis venous catheterization for renal dialysis percutaneous abdominal drainage transfusion of packed cells injection or infusion of cancer chemotherapeutic substance other radiotherapeutic procedure allogeneic hematopoietic stem cell transpant without purging removal of other device from thorax diagnoses: acute kidney failure with lesion of tubular necrosis unspecified essential hypertension other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure bacteremia infection with microorganisms without mention of resistance to multiple drugs other complications due to other vascular device, implant, and graft antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other constipation complications of transplanted bone marrow fever, unspecified nausea alone streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure headache hypovolemia other and unspecified infection due to central venous catheter accidents occurring in residential institution delirium due to conditions classified elsewhere epistaxis other abnormal glucose anemia in neoplastic disease portal vein thrombosis pain in limb acute graft-versus-host disease mucositis (ulcerative) due to antineoplastic therapy peripheral t cell lymphoma, unspecified site, extranodal and solid organ sites polyneuropathy in malignant disease 

Answer: The patient is high likely exposed to